Search research articles
Contact Us
Filters
Showing results (281-290 of 400) with videos related to
Page
of 40
Sort By:
MLO: Medical Laboratory Observer
|
May 22, 2009
Trends in rapid testing
Anderson Brian, Randy Pawlovich, Vincent Tumminello, et al.
Journal of Medicinal Chemistry
|
January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activity
F Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
February 1, 1986
Three-dimensional computed tomography in maxillofacial trauma
D P DeMarino, E Steiner, R B Poster, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs
Pauline W Ondachi, Zhuo Ye, Ana H Castro, et al.
ACS Chemical Neuroscience
|
October 12, 2016
Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues
Pauline W Ondachi, Ana H Castro, Benjamin Sherman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies
David Avigan, Parameswaran Hari, Minoo Battiwalla, et al.
Pediatric Blood & Cancer
|
February 19, 2016
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias
Nirali N Shah, Melinda S Merchant, Diane E Cole, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Plos One
|
December 11, 2012
Population estimation and trappability of the European badger (Meles meles): implications for tuberculosis management
Andrew W Byrne, James O'Keeffe, Stuart Green, et al.
Pharmacotherapy
|
February 13, 2013
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype
Brad Moriyama, Paul F Jarosinski, William D Figg, et al.
Page
of 40
Search research articles
Search
Showing results (281-290 of 400) with videos related to
Sort By:
Page
of 40
MLO: Medical Laboratory Observer
|
May 22, 2009
Trends in rapid testing
Anderson Brian, Randy Pawlovich, Vincent Tumminello, et al.
Journal of Medicinal Chemistry
|
January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activity
F Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
February 1, 1986
Three-dimensional computed tomography in maxillofacial trauma
D P DeMarino, E Steiner, R B Poster, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs
Pauline W Ondachi, Zhuo Ye, Ana H Castro, et al.
ACS Chemical Neuroscience
|
October 12, 2016
Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues
Pauline W Ondachi, Ana H Castro, Benjamin Sherman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies
David Avigan, Parameswaran Hari, Minoo Battiwalla, et al.
Pediatric Blood & Cancer
|
February 19, 2016
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias
Nirali N Shah, Melinda S Merchant, Diane E Cole, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Plos One
|
December 11, 2012
Population estimation and trappability of the European badger (Meles meles): implications for tuberculosis management
Andrew W Byrne, James O'Keeffe, Stuart Green, et al.
Pharmacotherapy
|
February 13, 2013
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype
Brad Moriyama, Paul F Jarosinski, William D Figg, et al.
Page
of 40